MHRA (UK) · Jun 9, 2026
MHRA launches AI sandbox to accelerate medicines development and improve safety
New AI sandbox will help make medicines safer, speed up development, and reduce reliance on animal testing.
Global Health
UK, EU & international health agencies
MHRA (UK) · Jun 9, 2026
Nipocalimab (Imaavy) authorised to treat adults and adolescents with generalised myasthenia gravis
As with all medicines, the MHRA will keep the safety and effectiveness of Nipolcalimab under close review.
MHRA (UK) · Jun 9, 2026
Promotional material: National AI Commission: Ask Me Anything
The MHRA hosted a live Ask Me Anything on how artificial intelligence (AI) is being regulated in healthcare.
MHRA (UK) · Jun 9, 2026
Guidance: AI Airlock Simulation Workshops
Key insights of simulation workshops from the AI Airlock testing programme. You should note that these documents are not formal guidance.
MHRA (UK) · Jun 9, 2026
Guidance: AI Airlock Sandbox Phase 2 Programme Report
The MHRA’s AI Airlock second phase ran between April 2025 and May 2026. This report does not constitute formal MHRA guidance.
UKHSA (UK) · Jun 9, 2026
Official Statistics: Weekly all-cause mortality surveillance: week ending 7 June 2026
How the actual number of deaths in England compare with expected numbers for each week.
UKHSA (UK) · Jun 9, 2026
Correspondence: National flu immunisation programme plan 2026 to 2027
The annual flu letter describes the national flu immunisation programme and outlines which groups are eligible for flu vaccination.
DHSC (UK) · Jun 9, 2026
Official Statistics: Adult social care client level data, England: quarterly update to December 2025
Official statistics in development on insights from client level data from local authorities, including information on assessments and long-term support.
DHSC (UK) · Jun 9, 2026
Official Statistics: Adult social care client level data, England: quarterly update to September 2025
Official statistics in development on insights from client level data from local authorities, including information on assessments and long-term support.
DHSC (UK) · Jun 8, 2026
Unpaid carers and parents of seriously ill children could get new rights under Government proposals
Government consults on new rights for unpaid carers and parents of seriously ill children, including whether paid leave could improve job opportunities.
DHSC (UK) · Jun 8, 2026
Millions to get faster eye care on the high street
Government invests £20 million to digitise referrals from the high street directly and digitally into NHS hospital eye services.
UKHSA (UK) · Jun 8, 2026
Training and events: UKHSA Knowledge and Library Services
Knowledge and Library Services provide a range of information skills training for eligible staff. Training is available in group or one-to-one settings.
DHSC (UK) · Jun 8, 2026
Embedding co-design and participation in early years services
Policy Lab worked with the Department of Health and Social Care to develop a co-design toolkit enabling parents and carers to shape early years services.
MHRA (UK) · Jun 8, 2026
Corporate report: Advertising investigations: May 2026
Decisions made by MHRA on adverts reported to have breached the legislation on advertising medicines.
MHRA (UK) · Jun 8, 2026
Clinical trials for medicines: modifying a clinical trial approval
Guidance on the various types of modifications that can be made to a clinical trial approval.
ECDC (EU) · Jun 8, 2026
MERS-CoV worldwide overview
Since April 2012, and as of 1 June 2026, a total of 2 649 MERS cases, including 960 deaths, have been reported by health authorities worldwide.
MHRA (UK) · Jun 8, 2026
Field Safety Notices: 1-5 June 2026
List of Field Safety Notices for 1-5 June 2026
UKHSA (UK) · Jun 8, 2026
Guidance: Carbon monoxide (CO): antenatal checks algorithm for midwives
An algorithm for midwives to help diagnose carbon monoxide poisoning in pregnant women and offer advice for pregnant women in the event of exposure.
DHSC (UK) · Jun 8, 2026
New guidance on screen use for children aged 5–16
First-ever government guidance on healthy screen use for children aged 5–16 .
MHRA (UK) · Jun 8, 2026
Class 4 Medicines Defect Notification: Cadila Pharmaceuticals Limited, Mirtazapine 30mg Tablets, EL(26)A/28
Cadila Pharmaceuticals Limited has informed the MHRA of an error with the European Article Number (EAN) barcode on the cartons of a batch of Mirtazapine 30mg Film-Coated Tablets distributed in Crescent Pharma Limited livery.
MHRA (UK) · Jun 8, 2026
Find product information about medicines
How to get information including patient information leaflets (PILs), details on how the medicine can be used (SPCs) and scientific reports (PARs).
UKHSA (UK) · Jun 8, 2026
Official Statistics: Weekly all-cause mortality surveillance: week ending 5 July 2026
How the actual number of deaths in England compare with expected numbers for each week.
UKHSA (UK) · Jun 8, 2026
Accredited official statistics: Quarterly Epidemiological Commentary: mandatory MRSA, MSSA and Gram-negative bacteraemia and Clostridioides difficile infection, data up to January to March 2026
Epidemiological analyses of mandatory surveillance data on healthcare associated infections (HCAI); MRSA, MSSA and Gram-negative bacteraemia (Escherichia coli (E. coli), Pseudomonas aeruginosa ( P. aeruginoa), Klebsiella species (Klebsiella spp.)), and Clostridioides difficile (C. difficile) infection.
UKHSA (UK) · Jun 8, 2026
Official Statistics: Respiratory syncytial virus (RSV) older adults vaccination coverage in England: May 2026
Insights on the vaccine uptake and commentary on the RSV (respiratory syncytial virus) vaccination programme for older adults.